http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010102214-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59c6a921f33fe0adc58c2b6177184515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_679e21720b3a2e6efbfe9172f3dfb425
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
filingDate 2010-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0706d94b217ae9663ee640dcc212ca2
publicationDate 2011-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2010102214-A3
titleOfInvention Method and composition for modulating canonical wnt pathway using folate and inositol
abstract The canonical Wnt signaling pathway is implicated in many disorders including neural tube defects, limb malformations, and heart defects, developmental disorders associated with alcohol exposure (fetal alcohol syndrome) or exposure to bipolar medications (i.e. lithium), wound healing, and Alzheimer's disease. Elevated plasma homocysteine (HCy), which results from folate (folic acid, FA) deficiency, the mood-stabilizing drug lithium (Li), and alcohol (ethanol) are linked to the induction of human congenital heart and neural tube defects. FA supplementation ameliorates the observed developmental errors in the Li- HCy, or alcohol-exposed mouse embryos and normalized heart function. Li, HCy or Wnt3A suppress Wnt-modulated Hex and Islet-1 expression. FA protects from the gene misexpression that is induced by all three factors. Administration of myo-inositol with FA synergistically enhances the protective effect.
priorityDate 2009-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004171559-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004234626-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008075714-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004043013-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397406
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135444779
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID614040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407914710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559587
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3028194
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579352

Total number of triples: 46.